VB 10 COV2
Alternative Names: SARS-CoV-2 T-cell vaccine; VB10.COV2Latest Information Update: 03 Dec 2021
At a glance
- Originator Vaccibody
- Developer Nykode Therapeutics
- Class COVID-19 vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II COVID 2019 infections